Francois Delvoye and Jean‐Philippe Désilles: Neutrophil Activation Affects Acute Ischemic Stroke Clinical Outcomes?
Francois Delvoye, Lecturer at the University of Liège (Belgium) and Research Coordinator at the Biological Resource Center of the Rothschild Foundation Hospital (Paris), shared an insightful post on LinkedIn:
”Check out our lab’s latest publication in JAHA!
Neutrophil activation at 24 hours after mechanical thrombectomy for acute ischemic stroke is correlated with 3-month clinical outcome.
Another argument for targeting neutrophil activation — as investigated in the NETs-Target clinical trial (NCT04785066), led by Prof. Jean-Philippe DESILLES at the Fondation Adolphe de Rothschild!”
Read the full article here.
Article: Neutrophil Activation 24 Hours After an Endovascular Therapy–Treated Acute Ischemic Stroke Is Associated With 3‐Month Clinical Outcome
Authors: François Delvoye, Benjamin Maier, Mialitiana Solonomenjanahary, Julien Labreuche, Lucas Di Meglio, Véronique Ollivier, Pierre Seners, Michel Piotin, Raphaël Blanc, Simon Escalard, Mikael Mazighi, Benoit Ho‐Tin‐Noé, Jean‐Philippe Désilles
Stay updated on the latest scientific advancements in the field of stroke with Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera